Novartis Opens Production Site In The US

2025-11-11 02:09:35

Alternative Headline:

(MENAFN- Swissinfo) Basel-based giant Novartis is opening a new radioligand therapy production site in California. This is part of the $23 billion (CHF18.5 billion) investment package in the United States already announced by the company. This content was published on November 11, 2025 - 10:42 2 minutes Keystone-SDA

Français fr Novartis ouvre un site de production aux Etats-Unis Original Read more: Novartis ouvre un site de production aux Etats

+Get the most important news from Switzerland in your inbox

The Carlsbad plant is the third site dedicated to this type of cancer treatment in the US, according to a press release issued on Monday by the pharmaceutical group.

The facility“expands production capacity to meet future demand”, according to Novartis, which says it also guarantees on-time delivery to virtually all patients across the US. The company is planning other sites in Florida and Texas.

+ How pharma became Switzerland's Achilles heel in the US

The plant south of Los Angeles is part of Novartis's $23 billion investment plan in the United States.

At the end of September, US President Donald Trump announced new 100% tariffs on medicines, unless the laboratories manufacture their treatments on US soil.

+ Switzerland braces for 100% US medicine tariff

Translated from French by DeepL/ts

MENAFN11112025000210011054ID1110328507

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.